Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis [version 2; referees: 2 approved]
Background: Antimalarial drugs affect the central nervous system, but it is difficult to differentiate the effect of these drugs from that of the malaria illness. We conducted a systematic review to determine the association between anti-malarial drugs and mental and neurological impairment in human...
Main Authors: | Mary A. Bitta, Symon M. Kariuki, Clifford Mwita, Samson Gwer, Leah Mwai, Charles R.J.C. Newton |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2017-06-01
|
Series: | Wellcome Open Research |
Subjects: | |
Online Access: | https://wellcomeopenresearch.org/articles/2-13/v2 |
Similar Items
-
Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? [version 1; referees: 2 approved]
by: Giovanni Grasso, et al.
Published: (2016-05-01) -
Is suvorexant a better choice than alternative hypnotics? [version 1; referees: 2 approved]
by: Daniel F. Kripke
Published: (2015-08-01) -
Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study [version 1; referees: 2 approved]
by: Sasha Gulati, et al.
Published: (2015-12-01) -
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; referees: 2 approved]
by: Daniel F. Kripke
Published: (2017-03-01) -
Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.
by: Bitta, M, et al.
Published: (2017)